249 related articles for article (PubMed ID: 21681515)
1. Evaluation of cervical conization as a definitive treatment for microinvasive cervical carcinoma and cervical intraepithelial neoplasia grade 3.
Takeda N; Suzuki T; Suzuki M; Matsuura M; Tanaka R; Fujii M; Ito E; Saito T
Arch Gynecol Obstet; 2012 Feb; 285(2):453-7. PubMed ID: 21681515
[TBL] [Abstract][Full Text] [Related]
2. Predictors of residual carcinoma or carcinoma-in-situ at hysterectomy following cervical conization with positive margins.
Diaz ES; Aoyama C; Baquing MA; Beavis A; Silva E; Holschneider C; Cass I
Gynecol Oncol; 2014 Jan; 132(1):76-80. PubMed ID: 24262876
[TBL] [Abstract][Full Text] [Related]
3. Endocervical curettage, cone margins, and residual adenocarcinoma in situ of the cervix.
Denehy TR; Gregori CA; Breen JL
Obstet Gynecol; 1997 Jul; 90(1):1-6. PubMed ID: 9207802
[TBL] [Abstract][Full Text] [Related]
4. Adenocarcinoma in situ of the cervix: management and outcome.
Azodi M; Chambers SK; Rutherford TJ; Kohorn EI; Schwartz PE; Chambers JT
Gynecol Oncol; 1999 Jun; 73(3):348-53. PubMed ID: 10366458
[TBL] [Abstract][Full Text] [Related]
5. Risk for residual adenocarcinoma in situ or cervical adenocarcinoma in women undergoing loop electrosurgical excision procedure/conization for adenocarcinoma in situ.
DeSimone CP; Day ME; Dietrich CS; Tovar MM; Modesitt SC
J Reprod Med; 2011; 56(9-10):376-80. PubMed ID: 22010519
[TBL] [Abstract][Full Text] [Related]
6. Adenocarcinoma in situ of the uterine cervix.
Muntz HG; Bell DA; Lage JM; Goff BA; Feldman S; Rice LW
Obstet Gynecol; 1992 Dec; 80(6):935-9. PubMed ID: 1448263
[TBL] [Abstract][Full Text] [Related]
7. Prediction of residual neoplasia based on histopathology and margin status of conization specimens.
Chang DY; Cheng WF; Torng PL; Chen RJ; Huang SC
Gynecol Oncol; 1996 Oct; 63(1):53-6. PubMed ID: 8898168
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathologic features of early adenocarcinoma of the cervix initially managed with cervical conization.
Poynor EA; Marshall D; Sonoda Y; Slomovitz BM; Barakat RR; Soslow RA
Gynecol Oncol; 2006 Dec; 103(3):960-5. PubMed ID: 16860853
[TBL] [Abstract][Full Text] [Related]
9. Management of patients with positive margins after cervical conization.
Lapaquette TK; Dinh TV; Hannigan EV; Doherty MG; Yandell RB; Buchanan VS
Obstet Gynecol; 1993 Sep; 82(3):440-3. PubMed ID: 8355949
[TBL] [Abstract][Full Text] [Related]
10. Adenocarcinoma in situ of the uterine cervix: an experience with 100 cases.
Ostör AG; Duncan A; Quinn M; Rome R
Gynecol Oncol; 2000 Nov; 79(2):207-10. PubMed ID: 11063645
[TBL] [Abstract][Full Text] [Related]
11. A study of diagnostic failure of loop conization in microinvasive carcinoma of the cervix.
Tseng CJ; Liang CC; Lin CT; Huang KG; Chou HH; Chang TC; Lai CH; Soong YK; Hsueh S
Gynecol Oncol; 1999 Apr; 73(1):91-5. PubMed ID: 10094886
[TBL] [Abstract][Full Text] [Related]
12. Management and follow-up of patients with adenocarcinoma in situ of the uterine cervix.
Poynor EA; Barakat RR; Hoskins WJ
Gynecol Oncol; 1995 May; 57(2):158-64. PubMed ID: 7729727
[TBL] [Abstract][Full Text] [Related]
13. Laser CO(2) conization: a safe mode of treating conservatively microinvasive carcinoma of the uterine cervix.
Diakomanolis E; Haidopoulos D; Rodolakis A; Vlachos G; Stefanidis K; Komisopoulos K; Michalas S
Eur J Obstet Gynecol Reprod Biol; 2004 Apr; 113(2):229-33. PubMed ID: 15063966
[TBL] [Abstract][Full Text] [Related]
14. Cold-knife and laser conization for cervical intraepithelial neoplasia.
Tabor A; Berget A
Obstet Gynecol; 1990 Oct; 76(4):633-5. PubMed ID: 2216193
[TBL] [Abstract][Full Text] [Related]
15. Cervical adenocarcinoma in situ: the predictive value of conization margin status.
Young JL; Jazaeri AA; Lachance JA; Stoler MH; Irvin WP; Rice LW; Andersen WA; Modesitt SC
Am J Obstet Gynecol; 2007 Aug; 197(2):195.e1-7; discussion 195.e7-8. PubMed ID: 17689647
[TBL] [Abstract][Full Text] [Related]
16. Analysis of Conservative Surgical Treatment and Prognosis of Microinvasive Squamous Cell Carcinoma of the Cervix Stage IA1: Results of Follow-Up to 20 Years.
Hartman CA; Teixeira JC; Barbosa SB; Figueiredo SM; Andrade LA; Bastos JF
Int J Gynecol Cancer; 2017 Feb; 27(2):357-363. PubMed ID: 27984378
[TBL] [Abstract][Full Text] [Related]
17. Adenocarcinoma in situ of the uterine cervix: management and outcome.
Widrich T; Kennedy AW; Myers TM; Hart WR; Wirth S
Gynecol Oncol; 1996 Jun; 61(3):304-8. PubMed ID: 8641606
[TBL] [Abstract][Full Text] [Related]
18. Is conization once following by simple hysterectomy sufficient for all clinical stage IA1 cervical squamous cell carcinoma?
Chen JR; Chiu ML; Wang TY; Chen TC; Wang KG; Su TH; Chang CL; Yang YC; Wang KL
Taiwan J Obstet Gynecol; 2013 Sep; 52(3):385-8. PubMed ID: 24075378
[TBL] [Abstract][Full Text] [Related]
19. [Risk factors of predicting residual disease in women with stage I a1 squamous cervical carcinoma after conization].
Zhu XE; Feng Y; Fu YF; Cheng XD; Chen XD; Xie X; Lü WG
Zhonghua Yi Xue Za Zhi; 2013 Feb; 93(7):534-6. PubMed ID: 23660325
[TBL] [Abstract][Full Text] [Related]
20. Prospective management of stage IA(1) cervical adenocarcinoma by conization alone to preserve fertility: a preliminary report.
Schorge JO; Lee KR; Sheets EE
Gynecol Oncol; 2000 Aug; 78(2):217-20. PubMed ID: 10926806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
